Last checked at 11 Oct 2017 07:00
RNS
For release: 11 October 2017
genedrive plc ("genedrive" or the "Company")
Notice of Preliminary Results
genedrive plc (LSE: GDR), the molecular diagnostics company, will be announcing its preliminary results for the twelve months ending 30 June 2017 on Tuesday 17 October, 2017.
David Budd, Chief Executive Officer, and Matthew Fowler, Chief Financial Officer, will host a presentation and simultaneous live conference call for analysts, followed by a Q&A session, at 11:00am on the day of the results. The presentation will be held at 85 Gresham Street, London, EC2R 7HE.
- Ends -
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
Matthew Fowler: Finance Director
Peel Hunt LLP
James Steel +44 (0)207 418 8900
Oliver Jackson
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
Notes to Editors
genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Further details can be found at: www.genedriveplc.com and www.genedrive.com.